These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7726506)

  • 21. Antibacterial activity of cefpodoxime against Branhamella catarrhalis.
    Takenouchi T; Nishino T
    Microbiol Immunol; 1991; 35(12):1059-71. PubMed ID: 1808460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous infection with Aggregatibacter actinomycetemcomitans].
    Böhme J; Glaenz TE; Kaiser A; Allmacher C
    Hautarzt; 2014 Sep; 65(9):810-3. PubMed ID: 25234630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.
    Piccolomini R; Catamo G; Di Bonaventura G
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3000-1. PubMed ID: 9797240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cefpodoxime on selected immunological functions and bacterial pathogenicity factors in vitro.
    Schubert S; Ullmann U
    Zentralbl Bakteriol; 1991 Jun; 275(2):233-40. PubMed ID: 1930575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium.
    Tanaka D; Miyasaki KT; Lehrer RI
    Oral Microbiol Immunol; 2000 Aug; 15(4):226-31. PubMed ID: 11154407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of cefpodoxime against pathogens causing respiratory, urinary or soft tissue infections].
    Silva F; Durán C; Ulloa MT; Prado V
    Rev Med Chil; 2005 Aug; 133(8):903-10. PubMed ID: 16163428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.
    Miyasaki KT; Bodeau AL; Ganz T; Selsted ME; Lehrer RI
    Infect Immun; 1990 Dec; 58(12):3934-40. PubMed ID: 2254020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids.
    Maisetta G; Batoni G; Esin S; Raco G; Bottai D; Favilli F; Florio W; Campa M
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1245-8. PubMed ID: 15728941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of fluorescent-labelled Actinobacillus actinomycetemcomitans strains to phagocytosis and killing by human neutrophils.
    Permpanich P; Kowolik MJ; Galli DM
    Cell Microbiol; 2006 Jan; 8(1):72-84. PubMed ID: 16367867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans.
    Johansson A; Claesson R; Hänström L; Kalfas S
    Eur J Oral Sci; 2003 Jun; 111(3):209-15. PubMed ID: 12786951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitans.
    Pavicić MJ; van Winkelhoff AJ; Pavivić-Temming YA; de Graaff J
    J Antimicrob Chemother; 1995 Feb; 35(2):263-9. PubMed ID: 7759390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.
    Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus to oxidative killing.
    Dongari AI; Miyasaki KT
    Oral Microbiol Immunol; 1991 Dec; 6(6):363-72. PubMed ID: 1668250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular 37-kDa antigenic protein from Actinobacillus actinomycetemcomitans induces TNF-alpha, IL-1 beta, and IL-6 in murine macrophages.
    Tani Y; Tani M; Kato I
    J Dent Res; 1997 Sep; 76(9):1538-47. PubMed ID: 9294487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
    Miyake Y; Tsuruda K; Okuda K; Widowati ; Iwamoto Y; Suginaka H
    J Periodontal Res; 1995 Jul; 30(4):290-3. PubMed ID: 7562327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered antigenicity is seen in the lipopolysaccharide profile of non-serotypeable Actinobacillus actinomycetemcomitans strains.
    Paju S; Saarela M; Chen C; Jousimies-Somer H; Uitto V; Asikainen S
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):171-7. PubMed ID: 10640613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of subinhibitory concentrations of ceftriaxone on opsonization and killing of Pseudomonas aeruginosa by human neutrophils.
    Labro MT; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1988 Sep; 22(3):341-52. PubMed ID: 3141346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
    Crosby JA; Kachlany SC
    Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.